News

Hypoglycaemia can be uncomfortable and even dangerous. Is it any wonder, then, that fear of hypoglycaemia contributes to diabetes burden and diabetes distress, particularly for parents whose children have ty...

Links between the presence of microvascular diabetic complications and worse outcomes in COVID-19 are well established. Now, however, new research suggests those linkages may reverberate way beyond the acute...

Premixed insulins have been around almost from the earliest decades of insulin manufacture. But as innovation in insulin design gathers pace, do they still have a role to play?

Nuts are a nutritional powerhouse. Might they be a prevention powerhouse too? Delegates at the 38th International Symposium on Diabetes and Nutrition heard presentations on their role in preventing and manag...

Hypoglycaemia presents particular challenges for older people, yet is frequently misdiagnosed in this group. In his new module, launching today, Professor Brian Frier sheds new light on this import...

The pandemic has provided healthcare professionals with a unique opportunity to make the most of a digital approach to diabetes care.

At the American Diabetes Association (ADA) 81st Scientific Sessions, two fascinating presentations on the evolution of diabetes nutrition therapy revealed how we’ve got to where we are today.

Topline results from the EMPEROR-Preserved Phase 3 trial suggest potential for empagliflozin as a treatment for heart failure with preserved ejection fraction. The as-yet-unpublished findings are due to be p...

People with type 1 diabetes have been pushing the boundaries of sporting excellence for the past 100 years. Now, thanks to technology like continuous glucose monitoring (CGM) and closed-loop, they are achiev...

Listening to your feedback continues to be at the forefront of ensuring the EASD e-Learning programme is up to date, evidence based and meets the needs of our learners.

If you want a deeper understanding of the COVID-19 vaccination landscape, Dr Marc Evans is here to help. This week on Horizons we’re launching part one of his two-part presentation, an in-depth survey ...

Look to the liver – for non-alcoholic fatty liver disease (NAFLD) has important links with type 2 diabetes and metabolic syndrome, and can worsen the risk of cardiovascular disease.

The human microbiome, its role in diabetes and whether we can modify it with diet was the subject of two presentations at the 38th International Symposium on Diabetes and Nutrition.

Early puberty timing is linked with type 2 diabetes and our increasing understanding of this could lead to targeted interventions in the future…

The discovery of insulin was one of the most remarkable breakthroughs in the history of medicine – and subsequent innovations have radically improved its use and flexibility, says Professor Kamlesh Khu...

Empowering women to choose the right contraception can make a huge difference to their lives – and to their experience of pregnancy should they choose that later down the line. This year’s Diabet...

The need for precision medicine to inform diabetes management decisions is widely understood, but how can we achieve it? Precision monitoring could be the enabler.

The latest module in EASD e-Learning’s course on metabolic surgery launches today, written and presented by Dr Dimitri Pournaras, a prolific researcher in the field, who is also a bariatric and metabol...

There are pros and cons to each of the non-surgical approaches designed to reduce bodyweight in people living with obesity and type 2 diabetes, and these were outlined at this year’s Diabetes UK Profes...

As bariatric surgery becomes more popular, we’re finding out more about its safety and outcomes. At the 2021 Diabetes UK Professional Conference, two experts explored its complications and benefits.

We now have unprecedented levels of research and development into drugs that can help manage cardiovascular risk, particularly in type 2 diabetes. Professor Naveed Sattar (University of Glasgow, UK) and Prof...